Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 33% ± 18% | |
interneuron | 4 studies | 26% ± 10% | |
GABAergic neuron | 3 studies | 32% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 36% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 1201.53 | 453 / 459 | 91% | 29.41 | 1017 / 1118 |
prostate | 94% | 627.83 | 231 / 245 | 91% | 13.38 | 456 / 502 |
adrenal gland | 97% | 525.12 | 249 / 258 | 27% | 2.50 | 63 / 230 |
brain | 86% | 821.76 | 2276 / 2642 | 36% | 5.09 | 256 / 705 |
skin | 75% | 1053.73 | 1350 / 1809 | 47% | 10.17 | 223 / 472 |
pancreas | 67% | 156.06 | 220 / 328 | 51% | 4.67 | 91 / 178 |
liver | 62% | 211.15 | 140 / 226 | 53% | 6.76 | 216 / 406 |
lung | 64% | 196.60 | 370 / 578 | 40% | 3.66 | 464 / 1155 |
thymus | 83% | 262.74 | 540 / 653 | 20% | 2.01 | 124 / 605 |
uterus | 62% | 171.96 | 105 / 170 | 36% | 4.47 | 167 / 459 |
kidney | 60% | 162.16 | 53 / 89 | 36% | 3.53 | 321 / 901 |
eye | 0% | 0 | 0 / 0 | 93% | 36.83 | 74 / 80 |
adipose | 92% | 651.45 | 1112 / 1204 | 0% | 0 | 0 / 0 |
bladder | 62% | 253.57 | 13 / 21 | 24% | 2.34 | 120 / 504 |
esophagus | 40% | 91.95 | 574 / 1445 | 35% | 4.97 | 64 / 183 |
heart | 69% | 225.96 | 595 / 861 | 0% | 0 | 0 / 0 |
spleen | 66% | 175.55 | 160 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 14.53 | 29 / 45 |
ovary | 40% | 115.37 | 72 / 180 | 24% | 2.49 | 102 / 430 |
blood vessel | 58% | 246.63 | 768 / 1335 | 0% | 0 | 0 / 0 |
muscle | 43% | 137.46 | 344 / 803 | 0% | 0 | 0 / 0 |
stomach | 26% | 50.96 | 93 / 359 | 15% | 1.23 | 44 / 286 |
intestine | 10% | 24.66 | 98 / 966 | 18% | 1.46 | 94 / 527 |
peripheral blood | 0% | 0.16 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031103 | Biological process | axon regeneration |
GO_0048681 | Biological process | negative regulation of axon regeneration |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0022038 | Biological process | corpus callosum development |
GO_0042995 | Cellular component | cell projection |
GO_0043204 | Cellular component | perikaryon |
GO_0045121 | Cellular component | membrane raft |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0098552 | Cellular component | side of membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0008201 | Molecular function | heparin binding |
GO_0035374 | Molecular function | chondroitin sulfate binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RTN4RL1 |
Protein name | Reticulon-4 receptor-like 1 (Nogo receptor-like 2) (Nogo-66 receptor homolog 2) (Nogo-66 receptor-related protein 3) (NgR3) |
Synonyms | NGRL2 NGRH2 |
Description | FUNCTION: Cell surface receptor. Plays a functionally redundant role in postnatal brain development and in regulating axon regeneration in the adult central nervous system. Contributes to normal axon migration across the brain midline and normal formation of the corpus callosum. Protects motoneurons against apoptosis; protection against apoptosis is probably mediated by MAG. Plays a role in inhibiting neurite outgrowth and axon regeneration via its binding to neuronal chondroitin sulfate proteoglycans. Binds heparin (By similarity). Like other family members, plays a role in restricting the number dendritic spines and the number of synapses that are formed during brain development . Signaling mediates activation of Rho and downstream reorganization of the actin cytoskeleton . . |
Accessions | Q86UN2 ENST00000331238.7 |